Menactra 49281-0589-05
Generic: Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen
- Manufacturer
- Sanofi Vaccines Us Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- January 14, 2005
- Listing Expires
- December 31, 2027
- Application
- BLA125089
Active Ingredients
| Ingredient | Strength |
|---|---|
| Neisseria Meningitidis Group A Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen | 4 ug/.5mL |
| Neisseria Meningitidis Group C Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen | 4 ug/.5mL |
| Neisseria Meningitidis Group W-135 Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen | 4 ug/.5mL |
| Neisseria Meningitidis Group Y Capsular Polysaccharide Diphtheria Toxoid Conjugate Antigen | 4 ug/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Selected Package
49281-0589-05Selected5 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-589-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-589-58)
External Resources